Seek
Volume 2
Issue 2 Spring

Article 1

May 2016

Exploring the Evidence, Cracking the Case
Jennifer Tidball
Kansas State University

Follow this and additional works at: https://newprairiepress.org/seek
Part of the Higher Education Commons

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative
Works 4.0 License.
Recommended Citation
Tidball, Jennifer (2012) "Exploring the Evidence, Cracking the Case," Seek: Vol. 2: Iss. 2.

This Article is brought to you for free and open access by New Prairie Press. It has been accepted for inclusion in
Seek by an authorized administrator of New Prairie Press. For more information, please contact cads@k-state.edu.

Tidball: Exploring the Evidence, Cracking the Case

K

a

n

s

a

s

S

t

a

t

e

U

n

i

v

e

r

Perspectives

s

i

t

y

Spring 2012

Exploring the evidence,
cracking the case
How nanotechnology is helping researchers
clue into pathogen, cancer biomarker detection

Several Kansas State University researchers are becoming
scientific detectives at the food safety and biomedical scenes.
Under the direction of Jun Li, associate professor of
chemistry, they are developing biosensors that can accurately
detect even tiny traces of pathogens, blood contamination
and cancer cells.

Jun Li

Recently, Li and collaborators — including Lateef Syed, a
doctoral candidate in chemistry from India — filed a patent for a
technique to detect blood contamination. Its commercial potential
earned Syed a Kansas State University Research Foundation doctoral
research scholarship.
The technique involves attaching chemicals to gold nanoparticles,
which light up when blood contamination is detected in a process
called chemiluminescence. This method can detect slight traces
of biomaterials from less than one blood cell, creating numerous
applications for hospitals and crime scene investigations.
"If you spray this material on the computer keyboard or
on a doorknob in a hospital, you can see even a slight trace of
contamination that otherwise is unnoticeable," Li said. "For crime
scene investigations it can chemically trace small amounts of blood,
leaving nothing to hide."
Other collaborators include Deryl Troyer, Kansas State University
professor of anatomy and physiology, as well as Judy Wu and Mark
Richter, both of the University of Kansas. The work was supported by the
Institute for Advancing Medical Innovation at the University of Kansas.
The institute has filed a provisional patent application for the technique.
A second project for Li and Syed uses carbon nanofibers to
create a biosensor chip that detects pathogens such as E. coli and
salmonella. The goal is to turn this biosensor into an easy-to-use
hand-held electronic device.
"It is important for this biosensor to be hand-held because it
could immediately analyze a sample on location and determine
contamination," Syed said. "This will make it possible to prevent
outbreaks through early-stage detection."

"All of our work centers on nanotechnology," Li said.
"It is an exciting area where we can solve health care and
food safety problems while protecting lives and preventing
financial loss."

Li has been contacted by companies interested in using the
biosensor chip. The researchers are now developing the chip to detect
viruses, which is important for food safety and biosecurity.
Li and Syed are collaborating on the biosensor chip project with
Christopher Culbertson, associate professor of chemistry. Their
work has been supported by the Canadian-based company Early
Warning Inc., as well as the U.S. Department of Homeland Security
through the Center of Excellence for Emerging and Zoonotic Animal
Diseases, or CEEZAD, at Kansas State University.
The team has published articles about this work in the journals
Electrophoresis and Electroanalysis. Syed has co-authored two more
articles, and the team has a third article submitted.
A third nanobiosensor project by Li is funded by a three-year
$444,000 National Institutes of Health grant. The project focuses on
cancer research and early detection of cancer-related enzymes. Cancer
patients have enzymes called proteases that tumor cells use to destroy
surrounding healthy cells so the tumor has room to grow.
"If we can detect those small concentrations of enzymes as cancer
biomarkers in a simpler and faster way, it can show us what stage the
cancer is and what treatment should be applied," Li said.
Duy Hua, university distinguished professor of chemistry, and
Annelise Nguyen, associate professor of diagnostic medicine and
pathobiology, are collaborators for this cancer-related research.
"Our work is quite interdisciplinary," Li said. "We have formed strong
collaborative partnerships that allow researchers to build on their strengths
and combine their expertise to save the lives of many cancer patients."
— Jennifer Tidball

